Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Rockenstein

Showing results (141-150 of 169) with videos related to

Pageof 17
Sort By:
British Journal of Pharmacology|August 14, 2014
Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disordersWolf Wrasidlo, Leslie A Crews, Igor F Tsigelny, et al.
Annals of Clinical and Translational Neurology|August 16, 2014
Disease-Modifying Effect of Adiponectin in Model of α-SynucleinopathiesKazunari Sekiyama, Masaaki Waragai, Hiroyasu Akatsu, et al.
Experimental & Molecular Medicine|February 17, 2021
Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cellsChangyoun Kim, Somin Kwon, Michiyo Iba, et al.
Journal of Neuroinflammation|December 20, 2015
Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson's diseaseChangyoun Kim, Emmanuel Ojo-Amaize, Brian Spencer, et al.
Science (New York, N.Y.)|February 26, 2005
Axonopathy and transport deficits early in the pathogenesis of Alzheimer's diseaseGorazd B Stokin, Concepción Lillo, Tomás L Falzone, et al.
Molecular Neurodegeneration|August 11, 2018
Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammationChangyoun Kim, Brian Spencer, Edward Rockenstein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 10, 2018
Doublecortin expression in CD8+ T-cells and microglia at sites of amyloid-β plaques: A potential role in shaping plaque pathology?Michael S Unger, Julia Marschallinger, Julia Kaindl, et al.
Cell Stem Cell|January 24, 2017
Pericytes of Multiple Organs Do Not Behave as Mesenchymal Stem Cells In VivoNuno Guimarães-Camboa, Paola Cattaneo, Yunfu Sun, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 11, 2014
Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like modelsDora Games, Elvira Valera, Brian Spencer, et al.
Nature Communications|November 4, 2010
A β-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brainMasayo Fujita, Shuei Sugama, Kazunari Sekiyama, et al.
Pageof 17

Showing results (141-150 of 169) with videos related to

Sort By:
Pageof 17
British Journal of Pharmacology|August 14, 2014
Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disordersWolf Wrasidlo, Leslie A Crews, Igor F Tsigelny, et al.
Annals of Clinical and Translational Neurology|August 16, 2014
Disease-Modifying Effect of Adiponectin in Model of α-SynucleinopathiesKazunari Sekiyama, Masaaki Waragai, Hiroyasu Akatsu, et al.
Experimental & Molecular Medicine|February 17, 2021
Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cellsChangyoun Kim, Somin Kwon, Michiyo Iba, et al.
Journal of Neuroinflammation|December 20, 2015
Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson's diseaseChangyoun Kim, Emmanuel Ojo-Amaize, Brian Spencer, et al.
Science (New York, N.Y.)|February 26, 2005
Axonopathy and transport deficits early in the pathogenesis of Alzheimer's diseaseGorazd B Stokin, Concepción Lillo, Tomás L Falzone, et al.
Molecular Neurodegeneration|August 11, 2018
Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammationChangyoun Kim, Brian Spencer, Edward Rockenstein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 10, 2018
Doublecortin expression in CD8+ T-cells and microglia at sites of amyloid-β plaques: A potential role in shaping plaque pathology?Michael S Unger, Julia Marschallinger, Julia Kaindl, et al.
Cell Stem Cell|January 24, 2017
Pericytes of Multiple Organs Do Not Behave as Mesenchymal Stem Cells In VivoNuno Guimarães-Camboa, Paola Cattaneo, Yunfu Sun, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 11, 2014
Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like modelsDora Games, Elvira Valera, Brian Spencer, et al.
Nature Communications|November 4, 2010
A β-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brainMasayo Fujita, Shuei Sugama, Kazunari Sekiyama, et al.
Pageof 17